CD107a (LAMP-1) Antibody, anti-mouse, REAfinity™
Synonyms: LAMP-1, LAMP1
RECOMBINANT EXTENDED VALIDATION
Bioz Star94/100 Bioz rating
10 Citations2 Images
Clone:
REA777 | 1D4B
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD107a (LAMP-1) Antibody, anti-mouse, REAfinity™

Intracellular flow cytometry applications
APC
Biotin
PE
Vio B515
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-111-319, 130-111-505
Description:
Splenocytes from BALB/c mice were fixed, permeabilized, and stained with CD107a (LAMP-1) antibodies or with the corresponding REA Control antibodies (left peak). Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application image
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
frozen – PFA
Species tested:
mouse
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-111-319, 130-111-505
Testing grade:
Fixation:
frozen – Acetone
Species tested:
mouse
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-111-319, 130-111-505
Testing grade:
Extended validation for CD107a (LAMP-1) Antibody, anti-mouse, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA777
1D4B
high

Cells were incubated with an excess of purified unconjugated CD107a (LAMP-1) (REA777) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for CD107a. C57BL/6 Milz were first stained with Viobility™ 405/452 Fixable Dye followed by a suitable counterstaining. Cells were then fixed and permeabilized followed by staining with CD107a antibodies. As a control, CD107a antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris and cell doublets were excluded from the analysis based on scatter signals and Viobility™ 405/452 Fixable Dye fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for CD107a (LAMP-1) Antibody, anti-mouse, REAfinity™
Overview

Clone REA777 recognizes the mouse CD107a antigen, a 110–140 kDa type I membrane protein which is heavily glycosylated from a 40 kDa core protein. CD107a, also known as lysosome-associated membrane protein 1 (LAMP-1), is a ligand for galaptin, an S-type lectin, and is located on lysosomal membrans that can be used to distinguish lysosomes from other organelles. It is expressed on epithelial cells, macrophages, as well as on cells of different organs in mice.

Additional information: Clone REA777 displays negligible binding to Fc receptors.

Alternative names

LAMP-1, LAMP1

Detailed product information

Technical specifications

Clone
REA777
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
CD107a (LAMP-1)
Molecular mass of antigen [kDa]
42
Distribution of antigen
dendritic cells, epithelial cells, granulocytes, macrophages, T cells, endothelial cells, platelets, neutrophils
Entrez Gene ID
RRID
AB_2654464, AB_2654465, AB_2654469, AB_2654468, AB_2654467, AB_2654466, AB_2654470, AB_2654463

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD107a (LAMP-1) Antibody, anti-mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?